Phase 1 Psoriasis trials recruiting now

All Psoriasis trials, every phase

Other phases for Psoriasis

Phase 1 Psoriasis trials

• A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
  NCT07038720 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
  NCT06888193 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Female · 14 locations
• A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
  NCT07129382 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 11 locations
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis
  NCT07024602 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
  NCT07290036 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 63 locations
• A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period
  NCT07733089 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
  NCT07033234 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118
  NCT06846710 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 9 locations
• Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants
  NCT07258745 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
  NCT05725876 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
  NCT06982352 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis
  NCT06628206 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
  NCT07455578 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 6 locations
• Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
  NCT05642182 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 260 locations
• To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
  NCT06376474 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.